Amedisys (Amedisys) Interest Expense

: $-31 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Amedisys's interest expense for the three months ended in Dec. 2023 was $ -8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-31 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Amedisys's Operating Income for the three months ended in Dec. 2023 was $ 46 Mil. Amedisys's Interest Expense for the three months ended in Dec. 2023 was $ -8 Mil. Amedisys's Interest Coverage for the quarter that ended in Dec. 2023 was 5.53. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amedisys Interest Expense Historical Data

The historical data trend for Amedisys's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-14.52

-11.04

-9.53

-22.23

-31.27

Amedisys Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense																-5.78	-7.52	-7.50	-8.02	-8.23

Amedisys Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-31 Mil.

Amedisys (NAS:AMED) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amedisys's Interest Expense for the three months ended in Dec. 2023 was $-8 Mil. Its Operating Income for the three months ended in Dec. 2023 was $46 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $425 Mil.

Amedisys's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	45.53	/	-8.234
	=	5.53

The higher the ratio, the stronger the company's financial strength is.

Amedisys (Amedisys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (NAS:AMED) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ADY:Germany ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Executives

Allyson Guidroz	officer: Chief Accounting Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard M Ashworth	director, officer: President and CEO	200 WILMOT ROAD, DEERFIELD IL 60015
Michael Paul North	officer: Chief Information Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Adam Y Holton	officer: Chief People Officer	C/O CHS INC., 5500 CENEX DRIVE, INVER GROVE HEIGHTS MN 55077
Denise M. Bohnert	officer: Chief Compliance Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Nick Muscato	officer: Chief Strategy Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard A Lechleiter	director	PO BOX 32890, LOUISVILLE KY 40232-2890
Bruce D Perkins	director	500 WEST MAIN STREET, LOUISVILLE KY 40202
Christopher Gerard	officer: Chief Operating Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Vickie L Capps	director	2985 SCOTT STREET, VISTA CA 92083
Teresa L. Kline	director	C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Jeffrey A Rideout	director	2142 DEER OAK WAY, DANVILLE CA 94506
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
Molly Joel Coye	director	AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
David L Kemmerly	officer: See Remarks	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816